For the quarter ending 2025-12-31, NMTC made $2,892,635 in revenue. -$1,437,890 in net income. Net profit margin of -49.71%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Product revenue | 2,892,635 | 3,007,546 | 1,696,050 | 1,386,550 |
| Cost of product revenue | 1,324,807 | 1,279,791 | 781,215 | 615,489 |
| Product gross profit | 1,567,828 | 1,727,755 | 914,835 | 771,061 |
| Collaborations revenue | - | 750,000 | - | - |
| Selling, general and administrative | 1,885,455 | 1,912,576.5 | 1,618,950 | 1,940,414 |
| Research and development | 1,389,680 | 1,895,107 | 1,182,485 | 1,510,663 |
| Total operating expenses | 3,275,135 | 3,807,683.5 | 2,801,435 | 3,451,077 |
| License revenue | - | - | 0 | - |
| (loss) income from operations | -1,707,307 | 170,071.5 | -1,886,600 | -2,680,016 |
| Other income, net | - | - | - | 19,058 |
| Fair value change in warrant liability | -222,740 | -37,347 | -319,625 | -390,351 |
| Financing costs | - | 60,437.333 | 9,325 | - |
| Other income | 46,677 | 31,686.667 | 75,432 | - |
| (loss) income before income taxes | -1,437,890 | 83,050.5 | -1,500,868 | -2,270,607 |
| Provision for income taxes | - | - | 0 | - |
| Net (loss) income | -1,437,890 | 83,050.5 | -1,500,868 | -2,270,607 |
| Basic (in dollars per share) | -0.03 | 0.005 | -0.03 | -0.07 |
| Basic (in shares) | 50,331,155 | -19,781,954.5 | 48,604,996 | 31,111,786 |
| Diluted (in dollars per share) | -0.03 | 0.005 | -0.03 | -0.07 |
| Diluted (in shares) | 50,331,155 | -19,781,954.5 | 48,604,996 | 31,111,786 |
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)